Advertisement
Advertisement
U.S. Markets close in 3 hrs 55 mins
Advertisement
Advertisement
Advertisement
Advertisement

BioRestorative Therapies, Inc. (BRTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.1499+0.3199 (+11.30%)
As of 12:04PM EDT. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 9/29/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 75.03
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 324.0000
52 Week Low 32.4600
50-Day Moving Average 33.0931
200-Day Moving Average 33.9379

Share Statistics

Avg Vol (3 month) 316.13k
Avg Vol (10 day) 322.72k
Shares Outstanding 53.49M
Implied Shares Outstanding 6N/A
Float 82.66M
% Held by Insiders 120.83%
% Held by Institutions 120.75%
Shares Short (Jul 14, 2022) 446.63k
Short Ratio (Jul 14, 2022) 42.63
Short % of Float (Jul 14, 2022) 41.55%
Short % of Shares Outstanding (Jul 14, 2022) 41.28%
Shares Short (prior month Jun 14, 2022) 451.72k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jul 06, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-37,061.39%

Management Effectiveness

Return on Assets (ttm)-82.79%
Return on Equity (ttm)-383.30%

Income Statement

Revenue (ttm)44k
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)-11.10%
Gross Profit (ttm)46k
EBITDA -16.22M
Net Income Avi to Common (ttm)-33.47M
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.32M
Total Cash Per Share (mrq)5.31
Total Debt (mrq)392.26k
Total Debt/Equity (mrq)1.95
Current Ratio (mrq)40.25
Book Value Per Share (mrq)-0.00

Cash Flow Statement

Operating Cash Flow (ttm)-4.11M
Levered Free Cash Flow (ttm)840.29k
Advertisement
Advertisement